Clarfeld Financial Advisors’s Amgen AMGN Stock Holding History

Clarfeld Financial Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$41K	Buy	+208	New	+$40.6K	0.03%	113

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Clarfeld Financial Advisors's AMGN Position: Q4 2018 in Review

Clarfeld Financial Advisors opened a new position in Amgen (AMGN) in Q4 2018: 208 shares worth $41K. The stake represents 0.03% of the portfolio and ranks #113 among its holdings.

1,892 funds tracked by Wall St. Rank hold AMGN as of Q4 2018.

Clarfeld Financial Advisors held 208 shares of Amgen worth $41K as of Q4 2018.
Amgen was a new Clarfeld Financial Advisors position in Q4 2018.
Amgen made up 0.03% of Clarfeld Financial Advisors's portfolio in Q4 2018, its #113 holding.
1,892 funds tracked by Wall St. Rank held Amgen as of Q4 2018.

Based on Clarfeld Financial Advisors's 13F filing for Q4 2018, filed 15 Feb 2019.